Center for Clinical and Translational Sciences (CCTS)

临床和转化科学中心 (CCTS)

基本信息

批准号：
10316843
负责人：
DANIEL D KARP
金额：
$ 185.96万
依托单位：
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-02-04 至 2024-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10316843
关键词：
2019-nCoV Administrative Supplement Adult Respiratory Distress Syndrome Antibodies Applications Grants Area Basic Science Biological Blinded Blood COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 treatment Cancer Center Case Series Cause of Death Childhood Clinical Clinical Research Clinical Sciences Clinical Trials Clinical and Translational Science Awards Collaborations Communities Data Deterioration Development Disease Doctor of Medicine Ebola Economically Deprived Population Education Elderly Emergency Situation Enrollment Environment Epidemic First Independent Research Support and Transition Awards Funding Goals Health Sciences Healthcare Hispanics Hospitals Human Immunoglobulin A Immunoglobulin G Immunoglobulin M Incidence Individual Influenza Influenza A Virus, H1N1 Subtype Informatics Institution Institutional Review Boards Intubation Knowledge Lesbian Gay Bisexual Transgender Queer Long Island Lung diseases Malignant Neoplasms Measles Meta-Analysis Middle East Respiratory Syndrome New York New York City Outcome Patients Phase Physicians Placebos Plasma Pneumococcal Pneumonia Process Randomized Reporting Research Research Contracts Research Methodology Research Personnel Research Training Resources Respiratory Failure Rice Rural SARS-CoV-2 antibody Safety Saline Science Serum Severe Acute Respiratory Syndrome Site South Texas Spanish flu Texas Therapeutic Time Training Translational Research Translations Treatment Efficacy Universities Workforce Development base biobank blood product clinical center clinical data warehouse computer science convalescent plasma design effective therapy efficacy evaluation experience falls improved influenza pneumonia innovation mortality risk next generation novel pandemic disease pandemic influenza patient population patient registry phase II trial placebo controlled trial programs respiratory science education skills translational scientist trial comparing trial design

项目摘要

In the first awarded CTSA class, the Center for Clinical and Translational Sciences (CCTS) formed the first multiple-institution CTSA, with The University of Texas Health Science Center at Houston (UTHSC-H) and The University of Texas M. D. Anderson Cancer Center (UT MDACC). Since its inception the CCTS has been achieving the primary goal of the Clinical and Translational Sciences Award (CTSA) program: to accelerate research to transform healthcare and train the next generation of translational scientists. Our initial proposal was about bringing individuals and resources together, educating investigators, and building teams. In our 2011 renewal we described our Lowering-The-Barriers program, which focused on removing a large number of impediments through initiatives such as IRB reciprocity, standard research contracts and subcontracts, clinical data warehouses, patient registries, and biobanks. Our efforts have been successful and aligned with the national CTSA program. In this cycle, we bring in 3 new partner institutions to broaden and diversify our CTSA: The University of Texas Health Science Center at Tyler (northeast Texas, rural, economically disadvantaged), Rice University (with strengths in computer science, education, and team science), and The University of Texas Rio Grande Valley (south Texas, education and physician resources to help our nearby Brownsville Clinical Research Unit perform clinical trials). Together we will effect 5 strategic goals: Strategic Goal 1: To provide our investigators, staff, trainees, and scholars with the skills and knowledge necessary to advance discoveries and their translation in the new environment of clinical and translational research (Workforce Development). Strategic Goal 2: To collaborate with all of our stakeholders in a mutually beneficial way to advance translation by furthering engagement and team science (Collaboration/Engagement). Strategic Goal 3: To integrate pediatric and geriatric patients, Hispanic patients with cancer, and the LGBTQ+ community into the full spectrum of clinical and translational research (Integration). Strategic Goal 4: To advance translational science by providing novel processes, increasing efficiency, and streamlining research (Methods/Processes). Strategic Goal 5. To create and apply innovative informatics solutions to advance translational research, train the CTSA workforce, disseminate best practices, engage communities and integrate clinical and basic research data (Informatics).

在首届 CTSA 类别中，临床和转化科学中心 (CCTS) 组建了第一个多机构 CTSA，包括德克萨斯大学休斯顿健康科学中心 (UTHSC-H) 和德克萨斯大学 MD 安德森癌症中心 (UT MDACC)。自CCTS成立以来，实现临床和转化科学奖 (CTSA) 计划的主要目标：加速旨在改变医疗保健并培训下一代转化科学家的研究。我们最初的建议旨在将个人和资源聚集在一起，教育调查人员并建立团队。在我们的 2011 年更新中，我们描述了“降低障碍”计划，该计划的重点是消除大量通过 IRB 互惠、标准研究合同和分包合同、临床数据仓库、患者登记处和生物库。我们的努力是成功的，并且与国家 CTSA 计划。在此周期中，我们引入了 3 个新的合作伙伴机构，以扩大我们的业务范围并使其多元化 CTSA：位于泰勒的德克萨斯大学健康科学中心（德克萨斯州东北部，农村，经济弱势）、莱斯大学（在计算机科学、教育和团队科学方面具有优势）、和德克萨斯大学里奥格兰德河谷分校（德克萨斯州南部）的教育和医师资源帮助我们附近的布朗斯维尔临床研究单位进行临床试验）。我们将一起实现 5 战略目标：战略目标 1：为我们的研究人员、工作人员、受训人员和学者提供在新环境中推进发现及其转化所需的技能和知识临床和转化研究（劳动力发展）。战略目标2：与所有人合作我们的利益相关者以互惠互利的方式通过进一步参与和推进翻译团队科学（协作/参与）。战略目标 3：整合儿科和老年科患者、西班牙裔癌症患者和 LGBTQ+ 群体进入全方位的临床治疗和转化研究（整合）。战略目标 4：通过以下方式推进转化科学：提供新颖的流程、提高效率并简化研究（方法/流程）。战略目标 5. 创建并应用创新信息学解决方案以推进转化研究、培训 CTSA 员工、传播最佳实践、吸引社区并整合临床和基础研究数据（信息学）。